MapLight Therapeutics MPLT
NASDAQ MPLT
$7.44 +0.16 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) EBIT (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) reported EBIT of -$63.55 million for Q2 2026, compared with -$30.66 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) EBIT (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MapLight Therapeutics' EBIT came in at -$209.09 million; for FY2025, it was -$169.08 million.

  • By year, EBIT came in at -$82.95 million in FY2024.
  • Five-year quarterly EBIT spans a low of -$83.38 million in Q4 2025 and a high of -$20.89 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 6.18 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 6.27 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.59 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 3.16 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.46 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.47 Bn
10 MapLight Therapeutics 340.28 Mn 340.28 Mn - -63.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -63.55 Mn
Dec 31, 2025 -83.38 Mn
Sep 30, 2025 -31.50 Mn
Jun 30, 2025 -30.66 Mn
Dec 31, 2024 -22.78 Mn
Sep 30, 2024 -20.89 Mn
API Access

MapLight Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=MPLT&period=max&api_key=YOUR_API_KEY